Pediatrix Medical Group (NYSE:MD) Shares Gap Up to $7.62

Pediatrix Medical Group, Inc. (NYSE:MD) gapped up prior to trading on Tuesday . The stock had previously closed at $7.62, but opened at $8.32. Pediatrix Medical Group shares last traded at $8.48, with a volume of 197,947 shares traded.

Analysts Set New Price Targets

MD has been the subject of several analyst reports. StockNews.com lowered shares of Pediatrix Medical Group from a “hold” rating to a “sell” rating in a report on Thursday, July 18th. Truist Financial decreased their price target on Pediatrix Medical Group from $10.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, July 15th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a “sell” rating to a “hold” rating and set a $8.00 target price on the stock in a report on Friday, June 7th. One investment analyst has rated the stock with a sell rating and five have given a hold rating to the stock. Based on data from MarketBeat.com, Pediatrix Medical Group presently has a consensus rating of “Hold” and an average price target of $8.70.

Pediatrix Medical Group Stock Performance

The stock has a market capitalization of $754.80 million, a PE ratio of -9.75, a PEG ratio of 1.64 and a beta of 1.56. The business’s 50 day moving average is $7.47 and its 200 day moving average is $8.48. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.15 by $0.02. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. The firm had revenue of $495.10 million for the quarter, compared to the consensus estimate of $496.25 million. On average, equities research analysts predict that Pediatrix Medical Group, Inc. will post 1.13 earnings per share for the current fiscal year.

Institutional Trading of Pediatrix Medical Group

Hedge funds have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC boosted its position in shares of Pediatrix Medical Group by 226.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 36,161 shares of the company’s stock valued at $336,000 after acquiring an additional 25,098 shares during the last quarter. Smith Graham & Co. Investment Advisors LP boosted its holdings in Pediatrix Medical Group by 51.5% in the 4th quarter. Smith Graham & Co. Investment Advisors LP now owns 534,621 shares of the company’s stock valued at $4,972,000 after purchasing an additional 181,662 shares during the last quarter. Louisiana State Employees Retirement System purchased a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at approximately $385,000. Federated Hermes Inc. increased its holdings in shares of Pediatrix Medical Group by 5.0% during the 4th quarter. Federated Hermes Inc. now owns 283,793 shares of the company’s stock worth $2,639,000 after buying an additional 13,497 shares during the last quarter. Finally, Wedge Capital Management L L P NC raised its position in shares of Pediatrix Medical Group by 66.8% during the 4th quarter. Wedge Capital Management L L P NC now owns 81,988 shares of the company’s stock valued at $762,000 after buying an additional 32,831 shares during the period. Institutional investors and hedge funds own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.